-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7c92bb7-02de-4038-98dd-b204191e8237&Preview=1 -
Date
12/4/2012 -
Company Name
Crux Biomedical -
Mailing Address
1455 Adams Drive Menlo Park, CA 94025 -
Company Description
The company is developing a retrievable Inferior Vena Cava (IVC) filter that promises to be a great improvement over existing modes of treatment. The device has been successfully tested in animal studies in
2006 and was recently implanted in humans. Crux is currently working with the FDA to design and implement large-scale human clinical trials. -
Website
http://www.cruxbiomedical.com -
Transaction Type
M&A -
Transaction Amount
$36,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
The acquisition will be paid for with all cash.













